Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on β1-integrin to promote normal liver development
Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on β1-integrin to promote normal liver development
复制标题
DOI:
10.1128/mcb.21.15.5122-5131.2001
复制
发表时间:
2001-08-01
影响因子:
5.3
通讯作者:
Deng, CX
中科院分区:
文献类型:
--
作者:
Einstein, M;Monga, SPS;Deng, CX
Smads serve as intracellular mediators of transforming growth factor beta (TGF-beta) signaling. After phosphorylation by activated type I TGF-beta receptors, Smad proteins translocate to the nucleus, where they serve as transcription factors and increase or decrease expression of TGF-beta target genes, Mice lacking one copy each of Smad2 and Smad3 suffered midgestation lethality due to liver hypoplasia and anemia, suggesting essential dosage requirements of TGF-beta signal components. This is likely due to abnormal adhesive properties of the mutant hepatocytes, which may result from a decrease in the level of the beta1-integrin and abnormal processing and localization of E-cadherin. Culture of mutant livers in vitro revealed the existence of a parallel developmental pathway mediated by hepatocyte growth factor (HGF), which could rescue the mutant phenotype independent of Smad activation. These pathways merge at the beta1-integrin, the level of which was increased by HGF in the cultured mutant livers. HGF treatment reversed the defects in cell proliferation and hepatic architecture in the Smad2(+/-); Smad3(+/-) livers.